Evidence map›Paper›PMID 41595231›Full record

ArticleCancers2026

Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma.

Wesley H Chou, Lucy Lawrence, Emma Neham, Shreeram Akilesh, Amy E Moran, Christopher L Corless, Lisa Langmesser, Beyza Cengiz, Kazumi Eckenstein, Jen-Jane Liu and 5 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Wesley H ChouDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-9345-5287
Lucy LawrenceDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0009-0001-2589-5555
Emma NehamDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.
Shreeram AkileshDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-3152-7991
Amy E MoranDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.
Christopher L CorlessKnight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Lisa LangmesserDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Beyza CengizKnight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Kazumi EckensteinKnight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Jen-Jane LiuDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-1947-4148
Sudhir IsharwalDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Christopher L AmlingDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Marshall C StrotherDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Nicholas H ChakiryanDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-9263-8957
George V ThomasKnight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-7416-8840

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Developing novel polytherapies for Non-Clear Cell Renal Cell CarcinomaR01CA250378 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI George Victor Thomas · 2021 to 2026
$1.9M
Novel Treatment Strategies for CancerR21CA259440 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI THOMAS, GEORGE VICTOR · 2021 to 2021
$288k
NCI NIH HHS P30 CA069533NCI NIH HHS R01 CA250378NCI NIH HHS R21 CA259440NIH HHS P30 CA069533NIH HHS P30 CA069533 13S5NIH HHS R01 CA250378NIH HHS R21 CA259440
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune checkpoint inhibitionproteomicsrenal cell carcinomatranscriptomics

Identifiers

PMID41595231
PMCPMC12838847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.